Radiation for hematologic malignancies: from cell killing to immune cell priming
Over the past half-century, the role of radiotherapy has been revolutionized, in part, by a shift from intent to directly kill cancer cells to the goal of priming anti-tumor immune responses that attack both irradiated and non-irradiated tumors. Stimulation of anti-tumor immunity depends on the inte...
Main Authors: | Bouthaina Dabaja, Michael Spiotto |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-06-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2023.1205836/full |
Similar Items
-
Harnessing the Immunological Effects of Radiation to Improve Immunotherapies in Cancer
by: Gary Hannon, et al.
Published: (2023-04-01) -
Immunogenic Cell Death in Hematological Malignancy Therapy
by: Zhaoyun Liu, et al.
Published: (2023-05-01) -
CAR T-cell therapy-transforming treatment of hematological malignancies
by: Shah Newaz Ahmed, et al.
Published: (2023-02-01) -
CAR T cell-based immunotherapy and radiation therapy: potential, promises and risks
by: Lusine Hovhannisyan, et al.
Published: (2023-05-01) -
The Hematology of Tomorrow Is Here—Preclinical Models Are Not: Cell Therapy for Hematological Malignancies
by: Lorena Arranz
Published: (2022-01-01)